Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant
Authors:
- P HoeverPHP Hoever
- S de HaasSHS de Haas
- R C SchoemakerRSR C Schoemaker
- J van GervenJGJ van Gerven
- 7 April 2010
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 87 (5) , 593-600
Abstract
Almorexant, a dual orexin receptor antagonist potentially representing a new class of sleep-promoting compounds, was administered in an ascending single-dose study to evaluate tolerability, pharmacokinetics, and pharmacodynamics. Seventy healthy male subjects were enrolled in this double-blind, placebo- and active-controlled study. Each dose level (1-1,000 mg) was investigated in a separate group of 10 subjects (6 on almorexant, 2 on placebo, 2 on zolpidem 10 mg). Almorexant was well tolerated with no signs of cataplexy. Peak plasma concentration (C(max)) was quickly attained (median time to maximum concentration (t(max)) ranged from 0.7 to 2.3 h), and plasma concentrations subsequently decreased quickly to ~20% of C(max) over the course of 8 h. Vigilance, alertness, and visuomotor and motor coordination were reduced following daytime administration of zolpidem or almorexant at doses of > or =400 mg. Population pharmacokinetic/pharmacodynamic modeling suggested that doses of ~500 mg almorexant and 10 mg zolpidem are equivalent with respect to subjectively assessed alertness.Keywords
This publication has 42 references indexed in Scilit:
- Role of GABAAreceptors in the physiology and pharmacology of sleepEuropean Journal of Neuroscience, 2009
- Zolpidem-induced amnesia and somnambulism: Rare occurrences?European Neuropsychopharmacology, 2009
- Use of computerized dynamic posturography to assess balance in older adults after nighttime awakenings using zolpidem as a referenceBMC Geriatrics, 2008
- Hypocretin/Orexin: A Molecular Link Between Sleep, Energy Regulation, and PleasureThe Journal of Neuropsychiatry and Clinical Neurosciences, 2007
- Saccades and pursuit: two outcomes of a single sensorimotor processThe Journal of Physiology, 2007
- The Efficacy and Safety of Drug Treatments for Chronic Insomnia in Adults: A Meta-analysis of RCTsJournal of General Internal Medicine, 2007
- Advances in the management of insomniaExpert Opinion on Pharmacotherapy, 2004
- Comparative Pharmacokinetics and Pharmacodynamics of Short-Acting HypnosedativesClinical Pharmacokinetics, 2004
- Clinical Pharmacokinetics and Pharmacodynamics of ZolpidemClinical Pharmacokinetics, 1995
- Electroencephalogram Effect Measures and Relationships Between Pharmacokinetics and Pharmacodynamics of Centrally Acting DrugsClinical Pharmacokinetics, 1992